A preliminary readout from a study could vindicate Allogene Therapeutics' stubborn belief in its off-the-shelf CAR-T ...

The latest effort to make healthy women believe they are ill is a new movie on perimenopause, “The M Factor 2: Before the ...

There is no end in sight for the Centers for Disease Control and Prevention’s leadership limbo, with the Trump administration ...

A new MRI method measures cardiac oxygen use in three minutes without catheters or radiation, offering a simpler way to study ...

The FDA approved a new medicine from Denali Therapeutics for Hunter syndrome, a notable decision by the agency after a string ...

Eli Lilly and the "societal obligation" of GLP-1s, Merck's Terns Pharma purchase, and more biotech news in today's Readout ...

GYN, I talked with patients about endometriosis almost every day. The conversations were often brief and fragmented, shaped ...

Centers for Disease Control and Prevention staff gathered Wednesday for what many hoped would be an announcement of the Trump ...

Sarepta Therapeutics’ next crop of medicines for muscular dystrophy appear to be safe and effective in early clinical trials, ...

A California bill would allow "not ultraprocessed" labels on foods, even as scientists debate definitions and courts question ...

On the lookout for its next blockbusters, Merck said it would buy Terns Pharmaceuticals, picking up a promising leukemia ...

Merck intends to buy Terns Pharmaceuticals, the developer of a promising leukemia treatment, for $6.7 billion ...